COMPARATIVE STEADY-STATE BIOAVAILABILITY OF CONVENTIONAL AND CONTROLLED-RELEASE FORMULATIONS OF ALBUTEROL

被引:18
作者
POWELL, ML
WEISBERGER, M
DOWDY, Y
GURAL, R
SYMCHOWICZ, S
PATRICK, JE
机构
[1] SCHERING PLOUGH CORP,DEPT DRUG METAB & PHARMACOKINET,60 ORANGE ST,BLOOMFIELD,NJ 07003
[2] SCHERING PLOUGH CORP,DEPT CLIN PHARMACOL,BLOOMFIELD,NJ 07003
关键词
D O I
10.1002/bdd.2510080506
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:461 / 468
页数:8
相关论文
共 50 条
[21]   COMPARATIVE BIOAVAILABILITY OF IMMEDIATE-RELEASE AND SUSTAINED-RELEASE PROCAINAMIDE AT STEADY-STATE IN CARDIAC PATIENTS [J].
VLASSES, PH ;
ROCCI, ML ;
PORRINI, KA ;
GREENSPON, AJ ;
FERGUSON, RK .
CLINICAL RESEARCH, 1983, 31 (02) :A634-A634
[22]   THE COMPARATIVE STEADY-STATE BIOAVAILABILITY OF THE ACTIVE INGREDIENTS OF MADECASSOL [J].
RUSH, WR ;
MURRAY, GR ;
GRAHAM, DJM .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1993, 18 (04) :323-326
[23]   STEADY-STATE PHARMACOKINETICS OF CONTROLLED RELEASE AND IMMEDIATE RELEASE FORMULATIONS OF REMOXIPRIDE IN PATIENTS WITH CHRONIC-SCHIZOPHRENIA [J].
TENCH, D ;
SONI, SD ;
ASHWOOD, T ;
MOVIN, G .
PSYCHOPHARMACOLOGY, 1990, 101 (01) :132-136
[24]   A COMPARATIVE-STUDY OF THE STEADY-STATE PHARMACOKINETICS OF IMMEDIATE-RELEASE AND CONTROLLED-RELEASE DILTIAZEM TABLETS (VOL 46, PG 243, 1994) [J].
LEEUWENKAMP, OR ;
VISSCHER, HW ;
MENSINK, CK ;
JONKMAN, JHG .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 47 (01) :88-88
[25]   INFLUENCE OF FOOD ON STEADY-STATE SERUM CONCENTRATIONS OF THEOPHYLLINE FROM 2 CONTROLLED-RELEASE PREPARATIONS [J].
LEFEBVRE, RA ;
BELPAIRE, FM ;
BOGAERT, MG .
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1988, 26 (08) :375-379
[26]   BIOAVAILABILITY OF INDOMETHACIN FROM 2 MULTIPLE-UNITS CONTROLLED-RELEASE FORMULATIONS [J].
BECHGAARD, H ;
BRODIE, RR ;
CHASSEAUD, LF ;
HOUMOLLER, P ;
HUNTER, JO ;
SIKLOS, P ;
TAYLOR, T .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 21 (06) :511-515
[27]   STEADY-STATE LITHIUM BLOOD LEVEL FLUCTUATIONS IN MAN FOLLOWING ADMINISTRATION OF A LITHIUM-CARBONATE CONVENTIONAL AND CONTROLLED-RELEASE DOSAGE FORM [J].
CALDWELL, HC ;
WESTLAKE, WJ ;
SCHRIVER, RC ;
BUMBIER, EE .
JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (2-3) :106-109
[28]   STEADY-STATE ASPIRIN AND METABOLITE PHARMACOKINETICS AFTER ADMINISTRATION OF IMMEDIATE-RELEASE AND CONTROLLED-RELEASE DOSAGE FORMS [J].
STRAUGHN, AB ;
WOOD, GC ;
MEYER, MC ;
HWANG, PTR ;
THAM, SY ;
PURICH, ED ;
CABANA, BE .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1985, 19 (06) :461-462
[29]   BIOAVAILABILITY OF PSEUDOEPHEDRINE FROM CONTROLLED-RELEASE FORMULATIONS IN THE PRESENCE OF GUAIFENESIN IN HUMAN VOLUNTEERS [J].
PADE, V ;
ALURI, J ;
MANNING, L ;
STAVCHANSKY, S .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1995, 16 (05) :381-391
[30]   STEADY-STATE PHARMACOKINETIC EVALUATION OF A NOVEL, CONTROLLED-RELEASE MORPHINE SUPPOSITORY AND SUBCUTANEOUS MORPHINE IN CANCER PAIN [J].
BRUERA, E ;
FAINSINGER, R ;
SPACHYNSKI, K ;
BABUL, N ;
HARSANYI, Z ;
DARKE, AC .
JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (07) :666-672